cobaltous chloride has been researched along with 4-toluenesulfonamide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, M; Chang, HY; Chen, HY; Chiang, YF; Hsia, SM; Huang, KC; Huang, TC; Lin, CE; Shieh, TM; Wang, KL; Wu, SC; Yang, ZY | 1 |
1 other study(ies) available for cobaltous chloride and 4-toluenesulfonamide
| Article | Year |
|---|---|
Para-toluenesulfonamide, a novel potent carbonic anhydrase inhibitor, improves hypoxia-induced metastatic breast cancer cell viability and prevents resistance to αPD-1 therapy in triple-negative breast cancer.
Topics: Animals; Antigens, Neoplasm; Breast Neoplasms; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Female; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; p38 Mitogen-Activated Protein Kinases; Triple Negative Breast Neoplasms; Vascular Endothelial Growth Factor A | 2023 |